Page last updated: 2024-10-31

midazolam and Endocrine System Diseases

midazolam has been researched along with Endocrine System Diseases in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Endocrine System Diseases: Pathological processes of the ENDOCRINE GLANDS, and diseases resulting from abnormal level of available HORMONES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ekbom, K1
Kalman, S1
Jakobsson, J1
Marcus, C1

Trials

1 trial available for midazolam and Endocrine System Diseases

ArticleYear
Efficient intravenous access without distress: a double-blind randomized study of midazolam and nitrous oxide in children and adolescents.
    Archives of pediatrics & adolescent medicine, 2011, Volume: 165, Issue:9

    Topics: Adolescent; Analgesics, Non-Narcotic; Anesthetics, Intravenous; Anesthetics, Local; Chi-Square Distr

2011